Menu Close

Artificial intelligence workplan to guide use of AI in medicines regulation

The EMA and theĀ Heads of Medicines AgenciesĀ (HMAs) have published an artificial intelligence (AI) workplan to 2028, setting out a collaborative and coordinated strategy to maximise the benefits of AI to stakeholders while managing the risks.

Read the workplan in full here.